Semen Indonesia (Persero) Tbk PT
IDX:SMGR
Semen Indonesia (Persero) Tbk PT
IDX:SMGR
Price:
3 240
IDR
-3.28%
Market Cap:
22T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SMGR Alert
Semen Indonesia (Persero) Tbk PT
3240
-110 (-3.28%)
| 52 Week Range |
3 240
6 500
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Semen Indonesia (Persero) Tbk PT
Balance Sheet
Balance Sheet Decomposition
Semen Indonesia (Persero) Tbk PT
Semen Indonesia (Persero) Tbk PT
| Current Assets | 17.8T |
| Cash & Short-Term Investments | 5T |
| Receivables | 5.2T |
| Other Current Assets | 7.6T |
| Non-Current Assets | 60.9T |
| Long-Term Investments | 140.3B |
| PP&E | 55.5T |
| Intangibles | 3.6T |
| Other Non-Current Assets | 1.6T |
| Current Liabilities | 13.6T |
| Accounts Payable | 7.2T |
| Accrued Liabilities | 1.5T |
| Short-Term Debt | 2.8T |
| Other Current Liabilities | 2.1T |
| Non-Current Liabilities | 21.7T |
| Long-Term Debt | 9.8T |
| Other Non-Current Liabilities | 12T |
Balance Sheet
Semen Indonesia (Persero) Tbk PT
Semen Indonesia (Persero) Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
451 384
|
526 086
|
1 178 801
|
1 351 861
|
2 402 713
|
2 815 167
|
2 930 598
|
2 954 992
|
6 007 333
|
6 939 841
|
|
| Cash |
451 384
|
526 086
|
1 178 801
|
1 351 861
|
2 402 713
|
2 815 167
|
2 183 489
|
2 316 851
|
2 726 752
|
2 528 506
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
747 109
|
638 141
|
3 280 581
|
4 411 335
|
|
| Short-Term Investments |
4 566 438
|
3 440 196
|
1 668 906
|
2 294 352
|
2 851 470
|
1 202 503
|
1 103 469
|
1 357 454
|
59 981
|
59 709
|
|
| Total Receivables |
3 432 557
|
3 628 641
|
4 018 284
|
4 995 015
|
5 959 717
|
6 859 591
|
6 038 038
|
6 049 505
|
5 884 666
|
6 268 929
|
|
| Accounts Receivables |
3 301 247
|
3 543 840
|
3 837 918
|
4 885 666
|
5 786 215
|
6 489 861
|
5 777 254
|
5 690 879
|
5 521 338
|
5 787 852
|
|
| Other Receivables |
131 309
|
84 801
|
180 366
|
109 348
|
173 502
|
369 730
|
260 784
|
358 626
|
363 328
|
481 077
|
|
| Inventory |
2 811 704
|
2 408 974
|
2 671 145
|
3 686 332
|
3 544 142
|
4 641 646
|
4 547 825
|
4 848 528
|
5 610 233
|
5 133 737
|
|
| Other Current Assets |
386 462
|
534 808
|
836 024
|
1 474 258
|
1 332 982
|
1 139 624
|
944 674
|
975 029
|
1 316 766
|
1 380 756
|
|
| Total Current Assets |
11 648 545
|
10 538 704
|
10 373 159
|
13 801 819
|
16 091 024
|
16 658 531
|
15 564 604
|
16 185 508
|
18 878 979
|
19 782 972
|
|
| PP&E Net |
20 221 067
|
25 167 683
|
30 846 750
|
32 532 508
|
32 391 950
|
56 601 702
|
56 053 483
|
58 839 075
|
57 805 992
|
56 771 009
|
|
| PP&E Gross |
20 221 067
|
25 167 683
|
30 846 750
|
32 532 508
|
32 391 950
|
56 601 702
|
56 053 483
|
58 839 075
|
57 805 992
|
56 771 009
|
|
| Accumulated Depreciation |
10 117 480
|
11 483 290
|
13 594 171
|
15 369 482
|
16 959 423
|
30 369 389
|
21 903 868
|
26 334 579
|
29 368 093
|
31 782 506
|
|
| Intangible Assets |
947 816
|
968 474
|
1 149 800
|
1 066 588
|
751 568
|
2 909 363
|
2 608 353
|
2 500 556
|
2 498 258
|
2 342 832
|
|
| Goodwill |
155 881
|
165 832
|
205 280
|
203 057
|
333 119
|
1 350 696
|
1 353 342
|
1 344 650
|
1 355 236
|
1 347 295
|
|
| Note Receivable |
22 861
|
42 591
|
17 284
|
13 347
|
0
|
443 133
|
847 015
|
1 218 766
|
1 158 799
|
427 137
|
|
| Long-Term Investments |
1 079 759
|
835 311
|
528 825
|
465 337
|
273 503
|
260 711
|
198 322
|
155 706
|
151 758
|
132 488
|
|
| Other Long-Term Assets |
255 745
|
434 524
|
1 105 799
|
985 996
|
942 672
|
1 582 931
|
1 381 125
|
1 522 066
|
1 110 990
|
1 016 796
|
|
| Other Assets |
155 881
|
165 832
|
205 280
|
203 057
|
333 119
|
1 350 696
|
1 353 342
|
1 344 650
|
1 355 236
|
1 347 295
|
|
| Total Assets |
34 331 675
N/A
|
38 153 119
+11%
|
44 226 896
+16%
|
49 068 650
+11%
|
50 783 836
+3%
|
79 807 067
+57%
|
78 006 244
-2%
|
81 766 327
+5%
|
82 960 012
+1%
|
81 820 529
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 031 508
|
3 783 246
|
4 077 757
|
4 927 077
|
4 476 149
|
5 669 759
|
6 520 699
|
7 855 288
|
8 095 924
|
8 096 285
|
|
| Accrued Liabilities |
1 125 631
|
1 482 480
|
1 544 845
|
1 356 305
|
1 294 002
|
1 957 574
|
1 902 261
|
1 985 868
|
1 885 878
|
1 400 402
|
|
| Short-Term Debt |
81 809
|
138 604
|
819 025
|
1 193 063
|
1 551 659
|
1 211 916
|
495 986
|
506 706
|
498 951
|
556 764
|
|
| Current Portion of Long-Term Debt |
516 070
|
707 082
|
991 502
|
727 449
|
138 523
|
2 080 329
|
1 614 429
|
3 477 609
|
775 524
|
4 636 670
|
|
| Other Current Liabilities |
516 912
|
487 779
|
718 544
|
599 683
|
719 486
|
1 320 674
|
972 788
|
806 761
|
1 804 750
|
1 421 539
|
|
| Total Current Liabilities |
5 271 930
|
6 599 190
|
8 151 673
|
8 803 577
|
8 179 819
|
12 240 252
|
11 506 163
|
14 632 232
|
13 061 027
|
16 111 660
|
|
| Long-Term Debt |
3 315 145
|
3 155 616
|
4 449 848
|
8 098 781
|
7 912 278
|
26 749 702
|
23 625 229
|
16 388 332
|
15 526 888
|
10 624 494
|
|
| Deferred Income Tax |
70 045
|
107 903
|
38 651
|
71 538
|
207 233
|
3 838 407
|
3 363 550
|
4 031 938
|
3 656 435
|
3 971 101
|
|
| Minority Interest |
958 465
|
1 021 257
|
1 539 196
|
1 524 057
|
1 423 230
|
1 615 109
|
1 479 926
|
4 361 511
|
4 491 146
|
4 539 485
|
|
| Other Liabilities |
669 625
|
849 613
|
1 012 332
|
2 048 721
|
1 869 191
|
3 086 782
|
3 857 967
|
3 838 813
|
3 476 302
|
3 312 298
|
|
| Total Liabilities |
10 285 210
N/A
|
11 733 577
+14%
|
15 191 700
+29%
|
20 546 675
+35%
|
19 591 751
-5%
|
47 530 252
+143%
|
43 832 835
-8%
|
43 252 826
-1%
|
40 211 798
-7%
|
38 559 038
-4%
|
|
| Equity | |||||||||||
| Common Stock |
593 152
|
593 152
|
593 152
|
593 152
|
593 152
|
593 152
|
593 152
|
593 152
|
675 154
|
675 154
|
|
| Retained Earnings |
21 519 826
|
23 814 977
|
26 556 913
|
26 369 270
|
28 642 706
|
29 803 211
|
32 068 753
|
34 169 728
|
35 317 015
|
35 832 127
|
|
| Additional Paid In Capital |
1 458 258
|
1 458 258
|
1 458 258
|
1 458 258
|
1 458 258
|
1 458 258
|
1 458 258
|
1 458 258
|
6 217 241
|
6 217 241
|
|
| Other Equity |
475 229
|
553 155
|
426 873
|
101 296
|
497 969
|
422 194
|
53 246
|
2 292 363
|
538 804
|
536 969
|
|
| Total Equity |
24 046 465
N/A
|
26 419 542
+10%
|
29 035 196
+10%
|
28 521 975
-2%
|
31 192 085
+9%
|
32 276 815
+3%
|
34 173 409
+6%
|
38 513 501
+13%
|
42 748 214
+11%
|
43 261 491
+1%
|
|
| Total Liabilities & Equity |
34 331 675
N/A
|
38 153 119
+11%
|
44 226 896
+16%
|
49 068 650
+11%
|
50 783 836
+3%
|
79 807 067
+57%
|
78 006 244
-2%
|
81 766 327
+5%
|
82 960 012
+1%
|
81 820 529
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
5 932
|
5 932
|
5 948
|
5 948
|
5 948
|
5 948
|
5 948
|
5 948
|
6 752
|
6 752
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
